We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+8.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$47.8B
AUM Growth
-$2.34B
(-4.7%)
Cap. Flow
-$5.56B
Cap. Flow
% of AUM
-11.64%
Top 10 Holdings %
Top 10 Hldgs %
32.03%
Holding
2,131
New
54
Increased
334
Reduced
1,616
Closed
126
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thomson Reuters
TRI
|
+$89.7M |
| 2 |
Fortinet
FTNT
|
+$69.3M |
| 3 |
Flowers Foods
FLO
|
+$37.9M |
| 4 |
Brown & Brown
BRO
|
+$28.6M |
| 5 |
Consolidated Edison
ED
|
+$24.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$626M |
| 2 |
Microsoft
MSFT
|
+$454M |
| 3 |
Apple
AAPL
|
+$414M |
| 4 |
Broadcom
AVGO
|
+$317M |
| 5 |
Amazon
AMZN
|
+$270M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Consumer Discretionary | 10.23% |
| 3 | Industrials | 9.49% |
| 4 | Communication Services | 9.26% |
| 5 | Financials | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Iovance Biotherapeutics
IOVA
$2.23B
| $125K | ﹤0.01% |
57,539
-7,502
| -12% | -$17.7K |
|
1802
Gogo Inc
GOGO
$515M
| $125K | ﹤0.01% |
14,512
-621
| -4% | -$7.87K |
|
1803
Lifestance Health
LFST
$4.16B
| $125K | ﹤0.01% |
22,657
-4,513
| -17% | -$22.1K |
|
1804
Vir Biotechnology
VIR
$1.47B
| $125K | ﹤0.01% |
21,820
-3,285
| -13% | -$16.8K |
|
1805
Rezolute
RZLT
$480M
| $124K | ﹤0.01% |
13,228
-499
| -4% | -$3.32K |
|
1806
Myriad Genetics
MYGN
$530M
| $124K | ﹤0.01% |
17,186
-3,155
| -16% | -$18.7K |
|
1807
Olema Pharmaceuticals
OLMA
$1.02B
| $124K | ﹤0.01% |
12,627
-2,139
| -14% | -$12.8K |
|
1808
Western Union
WU
$2.57B
| $121K | ﹤0.01% |
15,191
-1,139
| -7% | -$9.52K |
|
|
FFWM
1809
DELISTED
First Foundation Inc
FFWM
| $121K | ﹤0.01% |
21,716
+8,693
| +67% | +$48K |
|
|
RC
1810
Ready Capital
RC
$265M
| $121K | ﹤0.01% |
31,192
-6,083
| -16% | -$25.7K |
|
|
BRSP
1811
BrightSpire Capital
BRSP
$681M
| $120K | ﹤0.01% |
22,064
-4,397
| -17% | -$23.9K |
|
1812
Precigen
PGEN
$1.93B
| $119K | ﹤0.01% |
36,267
-5,518
| -13% | -$15.6K |
|
1813
Adtran
ADTN
$798M
| $119K | ﹤0.01% |
12,718
-2,534
| -17% | -$23.6K |
|
1814
Arvinas
ARVN
$518M
| $118K | ﹤0.01% |
13,834
-2,345
| -14% | -$17.8K |
|
1815
Marten Transport
MRTN
$1.33B
| $117K | ﹤0.01% |
10,983
-2,031
| -16% | -$24.7K |
|
1816
Akebia Therapeutics
AKBA
$327M
| $117K | ﹤0.01% |
42,750
-8,516
| -17% | -$28.3K |
|
|
UDMY
1817
DELISTED
Udemy
UDMY
| $116K | ﹤0.01% |
16,615
-3,310
| -17% | -$23.2K |
|
|
TERN
1818
DELISTED
Terns Pharmaceuticals
TERN
| $116K | ﹤0.01% |
15,481
-2,608
| -14% | -$16.7K |
|
1819
Digital Turbine
APPS
$1.02B
| $115K | ﹤0.01% |
17,910
-2,983
| -14% | -$14.8K |
|
|
BORR
1820
Borr Drilling
BORR
$1.31B
| $114K | ﹤0.01% |
42,337
-3,301
| -7% | -$8.21K |
|
1821
Sana Biotechnology
SANA
$885M
| $114K | ﹤0.01% |
32,030
-3,752
| -10% | -$13.6K |
|
|
INN
1822
Summit Hotel Properties
INN
$761M
| $113K | ﹤0.01% |
20,618
-3,882
| -16% | -$21.2K |
|
1823
Bloomin' Brands
BLMN
$680M
| $113K | ﹤0.01% |
15,697
-2,903
| -16% | -$23.3K |
|
|
DAWN
1824
DELISTED
Day One Biopharmaceuticals
DAWN
| $112K | ﹤0.01% |
15,956
-2,589
| -14% | -$17.8K |
|
|
ADAM
1825
Adamas Trust
ADAM
$777M
| $112K | ﹤0.01% |
16,009
-3,104
| -16% | -$21.6K |
|
Similar funds
ProShare Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, ProShare Advisors held 2,131 positions worth $47.8B, down 4.7% from $50.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
ProShare Advisors withdrew a net $5.56B in Q3 2025, closing 126 positions and reducing 1,616 holdings. Its most notable exit was Ansys, an estimated $48.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, ProShare Advisors opened a new position in Thomson Reuters worth $75.8M.
- ProShare Advisors's largest Q3 2025 buy was Thomson Reuters: 480,707 shares worth $75.8M.
- ProShare Advisors added most to Fortinet in Q3 2025, an estimated $69.3M increase.
- ProShare Advisors's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $626M.
- ProShare Advisors fully exited Ansys in Q3 2025, selling an estimated $48.7M.
- ProShare Advisors's ten largest holdings make up 32% of its $47.8B portfolio in Q3 2025.
- ProShare Advisors opened 54 new positions and closed 126 in Q3 2025.
- ProShare Advisors's portfolio value fell 4.7% quarter-over-quarter to $47.8B.
Based on ProShare Advisors's 13F filing for Q3 2025, filed 6 Nov 2025.